MPT0B640

DRUG2 trials

Sponsors

J Ints Bio

Conditions

Advanced Solid TumorCovid19Metastatic Solid Tumor

Early Phase 1

Phase I, FIH, MTD for MPT0B640, Multi-centre, Open-label, Subject With Locally Advanced or Metastatic Solid Malignancies

WithdrawnNCT04294875

J Ints BioAdvanced Solid Tumor, Metastatic Solid Tumor

Start: 2025-12-31End: 2027-11-30Updated: 2024-03-06

Phase 1

Heat Shock Protein Inhibitor- MPT0B640 for COVID-19 Infection

WithdrawnNCT04526717

J Ints BioCovid19

Start: 2021-12-31End: 2022-12-31Updated: 2021-06-11